Sign up
Log in
Cramer Says T-Mobile Is Being 'Hurt By The Death Star That's Elon Musk'
Share
Listen to the news

On CNBC's “Mad Money Lightning Round,” Jim Cramer said he likes Enterprise Products Partners LP (NYSE:EPD). “That's the one you want to be in,” he added.

On Dec. 2, Morgan Stanley analyst Robert Kad maintained an Equal-Weight rating on EPD and raised the price target from $33 to $34.

Lumentum Holdings Inc (NASDAQ:LITE) has had “such a run,” Cramer said. “I can't say yes to that.”

On Dec. 4, Rosenblatt analyst Mike Genovese maintained a Buy rating on Lumentum and raised the price target from $280 to $380.

Jim Cramer recommended not selling DuPont de Nemours Inc (NYSE:DD).

On Nov. 6, DuPont reported third-quarter 2025 results that exceeded Wall Street expectations but reduced its full-year outlook. Adjusted EPS came in at $1.09, beating the $1.06 estimate, while revenue rose 7% to $3.07 billion from $2.86 billion a year earlier, ahead of the $2.90 billion consensus.

T-Mobile US Inc (NASDAQ:TMUS) is being “hurt by the death star that's Elon Musk, and, I have to tell you, I would be worried too,” Cramer said. “I have to wait, it has not settled down yet.”

Goldman Sachs analyst Michael Ng, on Dec. 12, maintained T-Mobile with a Buy and lowered the price target from $287 to $251.

Price Action:

  • Enterprise Products Partners shares fell 0.3% to settle at $32.13 on Friday.
  • Lumentum shares dipped 12.8% to close at $324.35.
  • T-Mobile shares slipped 0.1% to settle at $195.16 on Friday.
  • DuPont shares fell 1.4% to close at $40.93.

Read Next:

Photo: Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.